$GNTX

Gentex (GNTX) director sells 5,939 Common Stock shares in market

Gentex Corp director Joseph B. Anderson Jr. sold 5,939 shares of Common Stock on May 15, 2026, at an average price of $22.9752 per share through an open-market transaction. This sale, valued at $136,450, resulted in his direct holding of Common Stock becoming 0 shares. The transaction was reported via a Form 4 filing, indicating a moderate impact and negative sentiment on the stock.

Original reporting
Published May 16, 2026, 4:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 16, 2026, 4:49 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$GNTX
Bearish
medium confidence
Mentioned
$GNTX · $GNTX
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$GNTXBearishMed
01

Why it matters

The insider sale could reflect personal financial planning rather than company outlook, but traders should remain cautious.

02

Market read

High relevance due to insider trading activity; potential short-term impact on stock price.

03

What to watch

Recent earnings reports, industry trends, and broader market movements could offset the negative signal from insider sales.

Timing: immediate, as the transaction occurred on May 15, 2026

Background

Gentex is a supplier of automotive mirrors and electronics, with its stock influenced by automotive industry trends.

Company-level read

Ticker impact

$GNTXBearishMedium confidence
Context

The insider sale by Gentex's director indicates a potential shift in insider sentiment, which could influence market perception.

Expected impact

Moderate decline in stock price over the next 1-2 weeks, approximately 3-5%.

Evidence & confidence

Insider sales are often viewed as a negative signal; however, they can also be personal liquidity events unrelated to company fundamentals. The magnitude and recentness of the sale support a cautious outlook.

$GNTXBearishMedium confidence
Context

The relevance score of 1.0 indicates high relevance, as insider trading activities are significant indicators for traders.

Expected impact

Short-term downward pressure, with potential stabilization after 2 weeks.

Evidence & confidence

While insider sales can influence sentiment, other factors such as earnings reports and market conditions will also impact the stock's trajectory.

Market effects

Potential negative sentiment in the automotive and manufacturing sectors, where Gentex operates.

Limited regional impact; primarily affects investors in the company's primary markets.

Minimal; the event is company-specific.

Counterpoint

The insider sale might be a personal liquidity event unrelated to company prospects; the stock could stabilize or rise if fundamentals remain strong.

Key entities

  • Gentex Corporation

    A manufacturer of automotive mirrors and electronics.

  • Joseph B. Anderson Jr.

    Director of Gentex who sold shares.

Related articles

$GNTXMedAI 8/10

Gentex Eyes $7B Revenue Path With Auto Tech, VOXX and Contract Manufacturing

Gentex (GNTX) aims for $4.5B-$7B revenue over 10 years, diversifying from auto mirrors to tech, VOXX, and manufacturing. It expects $2.5B revenue in 2025, with growth from Full Display Mirrors, driver-monitoring systems, and new products. VOXX acquisition exceeded targets, with improved margins and strategic value. Non-automotive revenue hit 14% in Q2. Gentex plans to expand contract manufacturing, targeting $1B-$2B revenue. The company returned $4.3B to shareholders over a decade and aims for $

$GNTXMed

GENTEX CORP (GNTX): Results of Operations and Financial Condition

GENTEX CORP (GNTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit99106302026.htm EX-99.1 Document Exhibit 99.1 GENTEX REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ZEELAND, MI -- (GLOBE NEWSWIRE - July 24, 2026) - Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire prote

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.